[The effect of parlodel on development of depressive syndrome in rats, caused by administering 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
N A
NA
Krupina
I N
IN
Orlova
G N
GN
Kryzhanovskiĭ
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000037:antagonists & inhibitors; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001971:Bromocriptine / Q000494:pharmacology*; D003866:Depressive Disorder / Q000139:chemically induced*; D004195:Disease Models, Animal; D018491:Dopamine Agonists / Q000494:pharmacology*; D004327:Drinking Behavior / Q000187:drug effects; D020267:MPTP Poisoning; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D017448:Receptors, Dopamine D2 / Q000819:agonists
D018491:Dopamine Agonists; D017448:Receptors, Dopamine D2; D001971:Bromocriptine; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Vliianie parlodela na razvitie depressivnogo sindroma u krys, vyzvannogo vvedeniem 1-metil-4-fenil-1,2,3,6-tetragidropiridina (MFTP).